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The debilitating complications of end-stage liver disease
(ESLD) are associated with substantial symptom burden.
These symptoms are often suboptimally controlled, resulting
in poor quality of life among those with ESLD (Fig. 1).1,2
What Is Palliative Care?
Palliative care (PC) is defined as ‘‘patient and family-
centered care that optimizes quality of life by anticipating,
preventing, and treating suffering’’ and should be consid-
ered for patients with advanced chronic illness, at any
point in disease trajectory.3 In contrast, hospice, which is a
component of PC, is appropriate for those whose life
expectancy is less than 6 months. Addressing end-of-life
issues through PC or hospice referral provides improved
communication between patients, their caregivers, and
their healthcare team; reduces symptom burden; and
enhances quality of life.4 In other diseases (non–small cell
lung cancer, pancreatic cancer, congestive heart failure),
PC and hospice can prolong life as well.5,6 From an insti-
tutional perspective, PC consultation can also be cost-
saving (Fig. 22).7 Despite all of this, end-of-life issues for
patients with cirrhosis are often not addressed until too
late, if at all.8
Utilization of PC in ESLD
A recent study by Poonja et al. demonstrated that, among
patients with decompensated cirrhosis with no curative
options (ie, removed from the liver transplantation<waiting
list or declined for transplant), only 11% were referred for
PC.2 Of those, only 28% had documented do not resusci-
tate (DNR) status. Our group demonstrated a similarly low
utilization rate of PC services among veterans with cirrhosis
who died within 1 year of cirrhosis diagnosis: only 7.5%
received PC services and, when they did, it was very late in
their disease trajectory (median of 32 days from PC consul-
tation to death) (Rakoski, unpublished data).
Barriers to PC
There is little literature that has explored barriers to PC
utilization among patients with ESLD. The following are
potential barriers (Table 1).
Disease Factors
Unlike the progressive decline that occurs with cancer,
ESLD is characterized by periods of relative stability inter-
posed with episodes of hepatic decompensation that can
result in rapid decline and death.
Patient Factors
Patients may have poor understanding of liver disease
severity and prognosis, due to inadequate physician com-
munication or poor health literacy. When faced with life-
limiting illness, some patients may also refuse to accept
prognosis. For some patients and their families, the pros-
pect of a life-saving intervention such as LT precludes con-
sideration of any treatment focus that does not offer
prolongation of life or cure. Misperception of PC (‘‘death
panels’’) and its association with ‘‘giving up’’ may also con-
tribute to underutilization.9 All of these issues may be fur-
ther exacerbated by hepatic encephalopathy and the
associated uncertainty about decisional capacity.
Physician Factors
In a web-based survey of intensive care nurses, house
officers, and attendings at a large liver transplant center,
84% of respondents indicated that the greatest barrier to PC
involvement in patients with ESLD was the attending physi-
cian.10 Potential physician-related barriers are multiple and
well described in other diseases: overestimation of life
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expectancy, misperception of or unfavorable attitudes
towards PC services, discomfort with end-of-life discus-
sions.11,12 This discomfort with end-of-life discussions
can be particularly challenging for a hepatologist who is
working with their patient toward a mutual curative goal
such as LT. Suboptimal end-of-life physician communication
can result in patients being unaware of their prognosis as
well as physicians being unaware of their patient’s end-of-
life preferences.13 Uncertainty and confusion about how
and when to integrate PC into standard ESLD management
may also result in under-referral,10 indicating the need for
guidelines to help guide timely and appropriate referral.
Access to PC
Although the number of PC programs is increasing and
the field of hospice and palliative medicine has recently
been granted subspecialty status, there remains a discrep-
ancy between the need for PC services and access to these
subspecialists. In 2012, only two-thirds of hospitals with
more than 50 beds had PC programs, and access remains
limited in smaller community hospital settings.14
Indications for PC in Patients with ESLD
A PC referral may be helpful for any patient with a life-
limiting illness who is experiencing suffering of any kind
(physical, emotional, spiritual, intrafamily conflict). The fol-
lowing are conditions for which a PC referral for a patient
with ESLD could be considered:
 Uncontrolled physical symptoms related to ESLD (eg, pain,
cramping, nausea, anorexia)
 Patient emotional or spiritual distress (eg, fear of dying;
guilt about prior behaviors like alcohol abuse that led to
ESLD)
 Family/caregiver emotional or spiritual distress (eg, ˚nan-
cial distress from taking off from work to care for patient;
strain associated with fluctuating mental status and unpre-
dictable hospitalizations15)
 Intrafamily conflict about goals of care (eg, patient has
severe hepatic encephalopathy or is intubated and family is
uncertain of patient’s desire for LT)
 Accelerating need for medical care or hospitalizations (eg,
refractory ascites requiring weekly paracenteses)
Figure 1 Symptomatology in patients with palliative cirrhosis according to
(revised) Edmonton Symptom Assessment System (ESAS)..2
Figure 2 Mean direct costs per day for palliative care (PC) patients (with
any chronic condition) who were (A) discharged alive or (B) died before and
after PC consultation. The solid line and dotted lines represent 2 different ways
of estimating costs if PC consultation had not occurred.7
TABLE 1 Potential Barriers to Utilization of PC Services
Barrier Mechanism
Disease Unpredictable episodes of decompensation
Patient Lack of knowledge of disease severity
Uncertainty about prognosis
Focus on liver-saving interventions
Distrust and misperception of PC (‘‘death panels’’)
Physician Overestimation of life expectancy
Misperception of PC
Discomfort with end-of-life discussions
Poor prognosis communication with patient
Focus on liver-saving interventions
Confusion regarding indications for PC referral
Access Improving, but potentially inadequate, access to PC services
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 Medical team has declined curative or life-sustaining treat-
ment (eg, patient denied LT listing or removed from the
transplant list)
 Patient has declined life-sustaining treatments
 Physician distress about caring for this patient (eg, diffi-
culty communicating a grim prognosis or lack of curative
options)
PC and LT: Divergent or Complementary?
For some, LT and PC seem like divergent treatment phi-
losophies, especially among those who equate PC with end-
of-life care.16 When pursuing life-saving interventions such
as transplantation, transplant physicians may feel compelled
to use medical innovation to its fullest extent in order to
prolong life, even when these efforts become increasingly
futile. The typical role of PC in LT involves consultation at
the time when a patient’s medical condition deteriorates to
the point that LT is no longer an option, which is often
only weeks to days before death. These barriers lead to
denial of valuable PC services for those who need it most.
Another way to view PC in this setting is as a tool to help
patients and families cope with the fear, uncertainty, and
loss of control inherent in the transplant waiting process.17
When viewed in this light, PC may be seen as a valuable
addition to LT services. This viewpoint is consistent with
the National Consensus Project for Quality Palliative Care
Clinical Practice Guidelines,3 which advocates for PC across
the illness trajectory, and has been successfully implemented
in some programs.18
Future Directions
Several possible avenues exist to improve the provision of
PC to patients with ESLD. One would be to enhance train-
ing in PC skills (eg, communication, pain management)
among gastroenterology and hepatology fellows, as well as
practicing hepatologists. This approach would allow contin-
ued patient-physician relationships with a hepatology pro-
vider that has familiarity with disease trajectory. However,
constraints of managing multiple medical issues during each
encounter would likely preclude adequate time for compre-
hensive PC. For this reason, PC consultation may enhance
this important aspect of patient care, ideally in close part-
nership with hepatology. In addition to such novel clinical
programs, more research is needed about the unmet needs
and barriers/facilitators to PC in this population.
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